Navigation For Mobile
  2. >
  3. coronavirus

Archives

Pharma Drug Innovation in 2020: From Novel Drugs to Drugs for Novel Coronavirus

Posted on September 2, 2020 by

Have other areas in drug discovery suffered because of COVID-19? It’s probably not too early to say that COVID-19 has changed pharmaceutical drug discovery considerably. And why wouldn’t it have,…

Posted in Chemistry, drug discovery, drugs, FDA, Neuland Labs, R&D, regulatory | Tagged , , | Comments Off on Pharma Drug Innovation in 2020: From Novel Drugs to Drugs for Novel Coronavirus

On-Site Pharma Audits During the Coronavirus (COVID-19) Crisis

Posted on May 3, 2020 by

The outbreak of COVID-19 has significantly impacted physical visits to drug manufacturing facilities. This raises a number of challenges, since many regulations — especially those relating to inspections — weren’t written with…

Posted in APIs, CMC, drugs, FDA, Quality, regulatory | Tagged , , , , | Comments Off on On-Site Pharma Audits During the Coronavirus (COVID-19) Crisis